Search results for 34

Acyl-CoA Dehydrogenase, C-4 To C-12 Straight Chain (ACADM) Antibody, Abbexa, abx001542

ACADM Antibody is a Rabbit Polyclonal antibody against ACADM. This gene encodes the medium-chain specific (C4 to C12 straight chain) acyl-Coenzyme A dehydrogenase. The homotetramer enzyme catalyzes the initial step of the mitochondrial fatty acid beta-oxidation pathway. Defects in this gene cause medium-chain acyl-CoA dehydrogenase deficiency, a disease characterized by hepatic dysfunction, fasting hypoglycemia, and encephalopathy, which can result in infantile death. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.

ACADM Rabbit mAb, ABclonal, A4567

Acyl-CoA Dehydrogenase, C-4 To C-12 Straight Chain (ACADM) Antibody, Abbexa, abx320311

ACADM Antibody is a Rabbit Polyclonal against ACADM.

Acyl Coenzyme A Dehydrogenase, C4-To-C12 Straight Chain (ACADM) Antibody, Abbexa, abx327607

ACADM Antibody is a Rabbit Polyclonal against ACADM.

ACADM antibody, Genetex, GTX43675

Interleukin 34 (IL34) Antibody (Biotin), Abbexa, abx317452

IL34 Antibody (Biotin) is a Rabbit Polyclonal against IL34 conjugated to Biotin.

Anti-VGlut3 Antibody (N34/34), AntibodySystem, RHN13001

RBC, Mouse, mAb 34-3C, Hycult Biotech, HM1120

The monoclonal antibody 34-3C recognizes an exposed surface determinant of intact red blood cells (RBC). The high-affinity anti-RBC monoclonal antibody efficiently bind to Fc receptors on macrophages inducing anemia in vivo due to a rapid Fc receptor (FcyR)-mediated erythrophagocytosis of opsonised RBC in spleen and livers. The capacity of the antibody to interact with FcyR is responsible for its haemolytic activity. The monoclonal antibody only recognises antigenic determinants expressed on Mouse RBC and not on other species of RBC.

Anti-RIM1 antibody [EPR29131-34], Abcam, AB317327

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-Riz1 antibody [EPR25164-34], Abcam, AB305105

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .